Co-diagnostics, inc. to host booth and discuss advancing poc/otc diagnostics at adlm 2024 in chicago

Salt lake city , july 29, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is hosting a booth at the association for diagnostics & laboratory medicine (adlm) annual meeting and expo held july 28-august 1, 2024, in chicago, il. co-dx will also be holding a special company presentation to discuss the role of its new at-home and point-of-care co-dx™ pcr platform* in closing the global diagnostics gap for an array of potential indications, including tuberculosis (tb).
CODX Ratings Summary
CODX Quant Ranking